<DOC>
	<DOCNO>NCT02330770</DOCNO>
	<brief_summary>Comparing reproductive outcome intracytoplasmic sperm injection ( ICSI ) cycle woman risk ovarian hyperstimulation syndrome ( OHSS ) subject gonadotropin release hormone ( GnRH ) antagonist protocol follow trigger concomitant GnRH agonist ( GnRHa ) low-dose human chorionic gonadotropin ( HCG ) administration ( dual trigger ) , GnRHa trigger single luteal low-dose HCG GnRHa trigger multiple luteal low-doses HCG</brief_summary>
	<brief_title>Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration</brief_title>
	<detailed_description>The GnRH antagonist fix protocol use control ovarian hyperstimulation ( COH ) . Transvaginal sonography ( TVS ) scan perform regularly monitor follicular growth ( folliculometry ) . When least 3 leading follicle &gt; 18 mm diameter , woman randomize 3 group ; group A ( dual trigger group ) , group B ( single low-dose HCG group ) group C ( multiple low-doses HCG group ) . In group A , final oocyte maturation trigger dual administration 0.2 mg GnRHa preparation ( Triptorelin ) SC 1500 IU HCG preparation IM . In group B , final oocyte maturation trigger administration 0.2 mg Triptorelin SC single IM bolus 1500 IU HCG administer 35-37 hour GnRHa trigger ( 1 hour oocyte retrieval ) . In group C , final oocyte maturation trigger administration 0.2 mg Triptorelin SC 3 IM bolus 500 IU HCG administer day 1 , day 4 day 7 oocyte retrieval . In woman , oocyte retrieval perform 34-36 hour trigger endometrial preparation embryo transfer ( ET ) start day oocyte retrieval give 400 mg vaginal natural progesterone supplement daily plus 4 mg oral estradiol valerate daily .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Women subject ICSI control ovarian hyperstimulation ( COH ) pituitary downregulation GnRH antagonist . Presence risk development OHSS : 1 ) previous moderate severe OHSS ; 2 ) PCOS polycystic ovary ultrasound scan ; 3 ) antral follicle count ( AFC ) &gt; 14 ovary ; 4 ) basal serum AMH level &gt; 3.36 ng/ml ; 5 ) &gt; 14 follicle diameter â‰¥ 11 mm day trigger oocyte maturation ; 6 ) E2 level &gt; 3000 pg/ml day trigger oocyte maturation . Age &lt; 20 year &gt; 35 year . BMI &lt; 19 kg/m2 &gt; 35 kg/m2 . Moderate severe endometriosis . Hydrosalpinx . Uterine abnormalities myoma . Previous uterine surgery . Use alternative technique minimize risk OHSS .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>GnRHa trigger</keyword>
	<keyword>Luteal phase support</keyword>
	<keyword>OHSS</keyword>
</DOC>